Janus Henderson Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $4.06M | Sell |
|
|||||
|
2023
Q3 | $18M | Sell |
|
|||||
|
2023
Q2 | $22.3M | Sell |
|
|||||
|
2023
Q1 | $32.6M | Sell |
|
|||||
|
2022
Q4 | $35.9M | Sell |
|
|||||
|
2022
Q3 | $65.5M | Buy |
|
|||||
|
2022
Q2 | $63.9M | Sell |
|
|||||
|
2022
Q1 | $73.5M | Sell |
|
|||||
|
2021
Q4 | $77.8M | Buy |
|
|||||
|
2021
Q3 | $85.2M | Sell |
|
|||||
|
2021
Q2 | $65.5M | Sell |
|
|||||
|
2021
Q1 | $66.4M | Sell |
|
|||||
|
2020
Q4 | $78.9M | Sell |
|
|||||
|
2020
Q3 | $72.2M | Sell |
|
|||||
|
2020
Q2 | $81.9M | Sell |
|
|||||
|
2020
Q1 | $80.9M | Sell |
|
|||||
|
2019
Q4 | $108M | Buy |
|
|||||
|
2019
Q3 | $99.9M | Sell |
|
|||||
|
2019
Q2 | $98.5M | Sell |
|
|||||
|
2019
Q1 | $89.5M | Sell |
|
|||||
|
2018
Q4 | $72.3M | Sell |
|
|||||
|
2018
Q3 | $130M | Sell |
|
|||||
|
2018
Q2 | $143M | Sell |
|
|||||
|
2018
Q1 | $100M | Buy |
|
|||||
|
2017
Q4 | $88.7M | Sell |
|
|||||
|
2017
Q3 | $108M | Sell |
|
|||||
|
2017
Q2 | $144M | Buy |
|